-
EP4314027
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4314027
| EP4314027 - METHODS AND MATERIALS FOR TARGETING TUMOR ANTIGENS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.01.2024 Database last updated on 03.01.2025 | |
| Former | The international publication has been made Status updated on 10.10.2022 | ||
| Former | unknown Status updated on 23.05.2022 | Most recent event Tooltip | 07.06.2024 | Change: Validation states | published on 10.07.2024 [2024/28] | 07.06.2024 | Change - extension states | published on 10.07.2024 [2024/28] | Applicant(s) | For all designated states The Johns Hopkins University 3400 North Charles Street Baltimore, Maryland 21218 / US | [2024/06] | Inventor(s) | 01 /
SMITH, Kellie N. Baltimore, Maryland 21222 / US | 02 /
CAUSHI, Justina Baltimore, Maryland 21287 / US | 03 /
HSIUE, Emily Han-Chung Baltimore, Maryland 21205 / US | 04 /
PARDOLL, Andrew M. Baltimore, Maryland 20833 / US | 05 /
ZHOU, Shibin Owings Mills, Maryland 21117 / US | 06 /
VOGELSTEIN, Bert Baltimore, Maryland 21208 / US | 07 /
KINZLER, Kenneth W. Frankford, Delaware 19945 / US | 08 /
PAPADOPOULOS, Nickolas Towson, Maryland 21204 / US | [2024/06] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [2024/06] | Application number, filing date | 22723242.8 | 31.03.2022 | [2024/06] | WO2022US22791 | Priority number, date | US202163168878P | 31.03.2021 Original published format: US 202163168878 P | [2024/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022212682 | Date: | 06.10.2022 | Language: | EN | [2022/40] | Type: | A2 Application without search report | No.: | EP4314027 | Date: | 07.02.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.10.2022 takes the place of the publication of the European patent application. | [2024/06] | Search report(s) | International search report - published on: | EP | 15.12.2022 | Classification | IPC: | C07K14/47, A61K35/17, C07K14/725, A61P35/00 | [2024/06] | CPC: |
C07K14/4746 (EP,US);
A61K35/17 (US);
A61K39/4611 (US);
A61K39/4632 (US);
A61K39/464411 (US);
A61K39/464451 (US);
A61K45/06 (US);
A61P35/00 (EP);
C07K14/7051 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/06] | Title | German: | VERFAHREN UND MATERIALIEN ZUM TARGETING VON TUMORANTIGENEN | [2024/06] | English: | METHODS AND MATERIALS FOR TARGETING TUMOR ANTIGENS | [2024/06] | French: | PROCÉDÉS ET MATÉRIAUX POUR LE CIBLAGE D'ANTIGÈNES TUMORAUX | [2024/06] | Entry into regional phase | 13.10.2023 | National basic fee paid | 13.10.2023 | Designation fee(s) paid | 13.10.2023 | Examination fee paid | Examination procedure | 13.10.2023 | Examination requested [2024/06] | 13.10.2023 | Date on which the examining division has become responsible | 06.05.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.10.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2018071796 (UNIV JOHNS HOPKINS [US]) [Y] 21,22,24,25 * abstract *; | [XY]WO2019067242 (US HEALTH [US]) [X] 1,2,6-20,23 * abstract * * paragraph [0068] * * paragraph [0118]; claims 1-21; table 1; sequence 4 * * paragraph [0093] * [Y] 21,22,24,25; | [A] - HAM SEOK WON ET AL, "TP53gain-of-function mutation promotes inflammation in glioblastoma", CELL DEATH & DIFFERENTIATION, NATURE PUBLISHING GROUP, GB, vol. 26, no. 3, doi:10.1038/S41418-018-0126-3, ISSN 1350-9047, (20180521), pages 409 - 425, (20180521), XP036699555 [A] 1-25 * the whole document * DOI: http://dx.doi.org/10.1038/s41418-018-0126-3 | [T] - CAUSHI JUSTINA X ET AL, "Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers", NATURE, NATURE PUBLISHING GROUP UK, LONDON, vol. 596, no. 7870, doi:10.1038/S41586-021-03752-4, ISSN 0028-0836, (20210721), pages 126 - 132, (20210721), XP037581371 [T] 1-25 * the whole document * DOI: http://dx.doi.org/10.1038/s41586-021-03752-4 | by applicant | - TUMEH et al., Nature, (20140000), vol. 515, pages 568 - 571 | - FORDE et al., N. Engl. J. Med., (20180000), vol. 378, pages 1976 - 1986 | - COTTRELL et al., Ann. Oncol., (20180000), vol. 29, pages 1853 - 1860 | - HARNDAHL et al., J. Biomol. Screen, (20090000), vol. 14, pages 173 - 180 | - LE et al., Science, (20170000), vol. 357, pages 409 - 413 | - SNYDER et al., N. Engl. J. Med., (20140000), vol. 371, pages 2189 - 2199 | - SCHUMACHER et al., Science, (20150000), vol. 348, pages 124 - 128 | - WARD et al., Adv Immunol, (20160000), vol. 130, pages 25 - 74 |